1. Home
  2. UVSP vs GERN Comparison

UVSP vs GERN Comparison

Compare UVSP & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Univest Financial Corporation

UVSP

Univest Financial Corporation

N/A

Current Price

$33.43

Market Cap

910.5M

Sector

Finance

ML Signal

N/A

Logo Geron Corporation

GERN

Geron Corporation

N/A

Current Price

$1.38

Market Cap

900.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UVSP
GERN
Founded
1876
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
910.5M
900.1M
IPO Year
1989
1996

Fundamental Metrics

Financial Performance
Metric
UVSP
GERN
Price
$33.43
$1.38
Analyst Decision
Hold
Buy
Analyst Count
3
7
Target Price
$33.00
$3.00
AVG Volume (30 Days)
144.6K
9.7M
Earning Date
01-28-2026
02-25-2026
Dividend Yield
2.63%
N/A
EPS Growth
19.65
N/A
EPS
2.98
N/A
Revenue
$309,144,000.00
$183,403,000.00
Revenue This Year
$13.32
$147.42
Revenue Next Year
$3.64
$37.07
P/E Ratio
$11.24
N/A
Revenue Growth
7.22
522.13
52 Week Low
$22.83
$1.04
52 Week High
$35.65
$3.09

Technical Indicators

Market Signals
Indicator
UVSP
GERN
Relative Strength Index (RSI) 51.89 55.97
Support Level $32.96 $1.34
Resistance Level $35.29 $1.44
Average True Range (ATR) 0.82 0.08
MACD 0.01 0.00
Stochastic Oscillator 42.54 61.36

Price Performance

Historical Comparison
UVSP
GERN

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: